Authors:
OWEN SM
ELLENBERGER D
RAYFIELD M
WIKTOR S
MICHEL P
GRIECO MH
GAO F
HAHN BH
LAL RB
Citation: Sm. Owen et al., GENETICALLY DIVERGENT STRAINS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 USE MULTIPLE CORECEPTORS FOR VIRAL ENTRY, Journal of virology, 72(7), 1998, pp. 5425-5432
Authors:
EDEN E
MITCHELL D
MEHLMAN B
KHOULI H
NEJAT M
GRIECO MH
TURINO GM
Citation: E. Eden et al., ATOPY, ASTHMA, AND EMPHYSEMA IN PATIENTS WITH SEVERE ALPHA-1-ANTITRYPYSIN DEFICIENCY, American journal of respiratory and critical care medicine, 156(1), 1997, pp. 68-74
Authors:
FORMAN SO
REDDY MM
MAZZA DS
MERINEY DK
GRIECO MH
Citation: So. Forman et al., EFFECT OF IMMUNOTHERAPY ON SCD23 LEVELS IN PATIENTS ALLERGIC TO HYMENOPTERA VENOM, Annals of allergy, asthma, & immunology, 77(4), 1996, pp. 282-284
Citation: J. Batterman et al., IN-VITRO RELEASE OF SOLUBLE CD23 BY HUMAN-LYMPHOCYTES IN RAGWEED-SENSITIVE VERSUS NONATOPIC PATIENTS FOLLOWING STIMULATION WITH RAGWEED ANTIGEN-E, Annals of allergy, asthma, & immunology, 76(4), 1996, pp. 359-362
Authors:
FISCHL MA
FINKELSTEIN DM
HE WL
POWDERLY WG
TRIOZZI PL
STEIGBIGEL RT
MAIEWSKI S
DALE E
MILLAR L
GOULD M
RATNER L
PARA MF
GOWER R
TENZLER R
FUHRER J
MILDVAN D
MALAMUD SC
DEZUBE B
CHAPMAN B
CRUMPACKER C
ISRAEL HB
FEINBERG J
HOOD A
RAINES CP
MILES SA
MITSUYASU RT
CARDEN J
MCMAHON D
PAZIN G
SCHULOF RS
CORTLESS JL
LELACHEUR SF
EHMANN WC
EYSTER ME
MCKINLEY GF
GRIECO MH
KOLATCH B
BENNETT JM
RYBAK ME
CHEESEMAN SH
KOUP RA
DIAMOND A
Citation: Ma. Fischl et al., A PHASE-II STUDY OF RECOMBINANT HUMAN INTERFERON-(ALPHA-2A) AND ZIDOVUDINE IN PATIENTS WITH AIDS-RELATED KAPOSIS-SARCOMA, Journal of acquired immune deficiency syndromes and human retrovirology, 11(4), 1996, pp. 379-384
Authors:
ENGLUND JA
BAKER CJ
RASKINO C
MCKINNEY RE
LIFSCHITZ MH
PETRIE B
FOWLER MG
CONNOR JD
MENDEZ H
ODONNELL K
WARA DW
SHLIOZBERG J
SHEARER WT
STECHENBERG B
BORKOWSKY W
BONAFORTE RJ
COOPER ER
WIZNIA A
TOLTZIS P
ISRAELE V
VANDYKE RB
YOGEV R
STARR S
OLESKE F
FRENKEL L
MCINTOSH K
MONTGOMERY M
PETRU A
SQUIRES JE
WADE N
MOORE EC
RAKUSAN TA
BAKER RC
BRADY MT
PILDES RS
CERVIA JS
WILFERT C
NESHEIM S
BELLANTI JA
KELLER M
ABRAMS EJ
DOSSETT JH
RANA SR
TISHLER DM
NICHOLAS SW
LAMBERT JS
WONG V
GUPTA A
DEVEIKIS A
KOVACS A
JOHNSON G
BAMJI M
SACKS HS
PAHWA S
GARCIARIAS D
FLYNN C
PHILIPP CS
JIMENEZ E
BONAGURA VR
SHENAP JL
GRIECO MH
LISCHNER H
MINNEFOR AB
MALDONADO Y
NACHMAN SA
FIKRIG S
WEINER LB
LEVIN M
GERSHON AA
BRYSON Y
SPECTOR S
DIAZ C
REICHMAN RR
ROBINSON J
LUZURIAGA K
CRAIN MJ
LIM W
RICH K
VINK PE
DOYLE MG
SCOTT GB
MUNOZ J
ANDIMAN WA
BEHRMAN R
HETHERINGTON S
MCLAREN C
MILLISON K
MOYE J
NOZYCE M
PEARSON DA
PURDUE L
SCHOENFELD D
SCOTT G
SPECTOR SA
Citation: Ja. Englund et al., CLINICAL AND LABORATORY CHARACTERISTICS OF A LARGE COHORT OF SYMPTOMATIC, HUMAN IMMUNODEFICIENCY VIRUS-INFECTED INFANTS AND CHILDREN, The Pediatric infectious disease journal, 15(11), 1996, pp. 1025-1036
Authors:
NEJAT M
HARALABALOS I
MAZZA DS
MERINEY DK
REDDY M
CLEVELAND L
GRIECO MH
Citation: M. Nejat et al., THE RELATIONSHIP BETWEEN CD23 AND IGE IN ATOPICS AND NON-ATOPICS, Journal of allergy and clinical immunology, 97(1), 1996, pp. 448-448
Authors:
LEPORT C
CHENE G
MORLAT P
LUFT BJ
ROUSSEAU F
PUEYO S
HAFNER R
MIRO J
AUBERTIN J
SALAMON R
VILDE JL
BLANC AP
SCHMITT JL
ARLAUD J
ESTAVOYER JM
GUILLEVIN L
BENTATA M
BEYLOT J
LACUT JY
GRANIER P
COSNARD F
BAZIN C
DORMONT J
REY M
DELAUNAY C
TROISVALLET D
MICOUD M
WEINBRECK P
TREPO C
GALLAIS H
GASTAUT JA
ALLARD C
JANBON F
CANTON P
GROLLEAU JY
CASSUTO J
DELLAMONICA P
DURET P
FROTTIER J
HERSON S
SELIGMANN M
SERENI D
GIRAUDON BB
DIEN G
RUEL M
STORCK D
JAUBERT D
LAFEUILLADE A
MOUTON Y
CHOUTET P
LAFAIX C
GATELL JM
GUELAR A
MILDVAN D
SOIERO R
JACOBSON JM
MURRAY HW
STEIGBIGEL NH
SACHS HH
VALENTINE F
GRIECO MH
ARMSTRONG D
LEDERMAN M
BARTLETT JA
WASKIN HA
NICHOLAS P
FESSEL JW
MACARTHUR RD
GLATT AE
PHAIR JP
POWDERLY W
HEWITT R
STEIGBIGEL RT
BLAIR DC
SKAHAN KJ
FRAME P
CHEESEMAN SH
CONNOR EM
BALFOUR HH
VANDERHORST C
HO M
Citation: C. Leport et al., PYRIMETHAMINE FOR PRIMARY PROPHYLAXIS OF TOXOPLASMIC ENCEPHALITIS IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION - A DOUBLE-BLIND,RANDOMIZED TRIAL, The Journal of infectious diseases, 173(1), 1996, pp. 91-97
Citation: Ds. Mazza et al., SERUM IGE IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION, Annals of allergy, asthma, & immunology, 74(5), 1995, pp. 411-414
Authors:
STROUD LA
TOKARS JL
GRIECO MH
CRAWFORD JT
CULVER DH
EDLIN BR
SORDILLO EM
WOODLEY CL
GILLIGAN ME
SCHNEIDER N
WILLIAMS J
JARVIS WR
Citation: La. Stroud et al., EVALUATION OF INFECTION-CONTROL MEASURES IN PREVENTING THE NOSOCOMIALTRANSMISSION OF MULTIDRUG-RESISTANT MYCOBACTERIUM-TUBERCULOSIS IN A NEW-YORK-CITY HOSPITAL, Infection control and hospital epidemiology, 16(3), 1995, pp. 141-147
Authors:
ROTH LC
CANNIZZARO M
REDDY MM
MAZZA DS
MERINEY DK
CLEVELAND WL
GRIECO MH
Citation: Lc. Roth et al., THE EFFECT OF ANTIGEN-E, INTERLEUKIN-2 AND INTERLEUKIN-4 STIMULATION ON IN-VITRO RELEASE OF SOLUBLE CD23 IN RAGWEED SENSITIVE VS NONATOPIC PATIENTS, Journal of allergy and clinical immunology, 95(1), 1995, pp. 336-336
Authors:
DOLIN R
AMATO DA
FISCHL MA
PETTINELLI C
BELTANGADY M
LIOU SH
BROWN MJ
CROSS AP
HIRSCH MS
HARDY WD
MILDVAN D
BLAIR DC
POWDERLY WG
PARA MF
FIFE KH
STEIGBIGEL RT
SMALDONE L
CRUMPACKER CS
COOLEY T
MITSUYASO RT
JOHN R
SANDERS C
REITMAN D
HEWITT R
REICHMAN RC
GELB LD
MCGUIRE ML
JONES M
NEIDIG JL
ZWICKL B
HARTMAN PB
ROARKE ME
BURK RA
FUHRER J
SOMOGYI KA
SEPKOWITZ K
TELZAK EE
MCAULIFFE VJ
VALENTINE FT
VASQUEZ M
MERIGAN TC
KATZENSTEIN D
FESSELL J
HAVLIR DV
RICHMAN DD
SPECTOR SA
KAHN JO
JOHNSON L
COLEMAN R
HO M
MCMAHON D
PAZIN G
ANTONISKIS D
MCNAMARA B
DIAMOND D
COLLIER AC
PARADISE MA
WALD A
DEPAOLISJONES A
HENRY K
WASKIN HA
HYSLOP NE
MUSHATT DM
ZACHARY JA
SOEIRO R
HARRIS C
ZINGMAN B
GIORDANO MF
SLEDZ S
MURRAY HW
CAREY JT
DAVIS TL
BAGBY B
KESSLER HA
MURPHY RL
HIRSCHTICK RE
CHEESEMAN SH
LAI KK
FAIRCHILD PG
EHMANN WC
ZURLO JJ
MILLARD R
TROIANI L
HEGGEN AA
VANDERHORST CM
MCKINLEY GF
GRIECO MH
KOLATCH BR
GOLDSMITH JC
GOMPERTS ED
WOODS LM
GRUE L
MAYJO K
BECKER RL
JAYAWEERA DT
ROLFE L
COLE J
JERMANO J
Citation: R. Dolin et al., ZIDOVUDINE COMPARED WITH DIDANOSINE IN PATIENTS WITH ADVANCED HIV TYPE-1 INFECTION AND LITTLE OR NO PREVIOUS EXPERIENCE WITH ZIDOVUDINE, Archives of internal medicine, 155(9), 1995, pp. 961-974
Authors:
FISCHL MA
STANLEY K
COLLIER AC
ARDUINO JM
STEIN DS
FEINBERG JE
ALLAN JD
GOLDSMITH JC
POWDERLY WG
RAINES CP
MAYJO KJ
KERULY JC
CRAVEN D
HIRSHORN L
HIRSCH MS
JAYAWEERA DT
YOUNG SW
PATRONEREESE J
BRETTLER D
SPERBER K
GERITS P
SEREMETIS S
GILL JC
GELB LD
MCGUIRE ML
STIFFLER T
LEDERMAN MM
CAREY JT
WALLACE M
MACARTHUR RD
BERGE P
MILDVAN D
COREY L
COOMBS RW
CUMMINGS DK
SCHOOLEY RT
RAY MG
WAITE V
KURITZKES DR
FUHRER J
TENZLER RJ
DONLON W
VANDERHORST CM
TROIANI L
HORTON J
LANE TW
MURPHY RR
PHAIR JP
KESSLER HA
BENSON CA
ROSENWALD V
YONREN S
VALENTINE F
HASLETT P
MITSUYASU RT
GUERRO M
GOETZ MB
MATHISEN GE
FRAME PT
BRINKDOPKE J
POWELL T
HOELLE M
MERIGAN TC
SHAFER R
CAIN P
FESSELL J
HENRY K
RHAME F
CHRISTENSON J
STRYKE D
ZINGMAN B
KAHL P
SOEIRO R
CHOI YS
REICHMAN RL
REID J
BLAIR DC
STEIGBIGEL RT
HEWITT RG
CAMERON ML
DONNELLY MA
PACKARD MV
BARTLETT JA
FIFE KH
ZWICKL BW
BORUM J
BURACK JH
DYBECK KA
COLEMAN RL
JOHNSON WR
MCKINLEY GF
GRIECO MH
KOLATCH BR
SEPKOWITZ K
PONTICELLO L
GIORDANO MF
MURRAY HW
GOCKE DJ
FASS RJ
PARA MF
STERN JS
DREW LJ
SPECTOR SA
HAVLIR DV
NUFFER KL
RICHMAN DD
CONNOR EM
KLOSER PC
PICARDI JM
VANMATERMINER C
LEEDOM JM
HOLTOM PD
RICHARDSON W
EHMANN WC
ZURLO JJ
KREHER M
EYSTER ME
HYSLOP NE
MUSHATT DM
HOADLEY DJ
ZACHARY JA
SIMON GL
PARENTI DM
LELACHEUR S
SCHUCK S
HO MT
MCMAHON DK
PAZIN GJ
ROSENER R
CHEESEMAN SH
MANGINI LA
SANDS MG
KAZIAL K
JONES G
PETTINELLI CB
LANDRY B
MARTINEZ AI
Citation: Ma. Fischl et al., COMBINATION AND MONOTHERAPY WITH ZIDOVUDINE AND ZALCITABINE IN PATIENTS WITH ADVANCED HIV DISEASE, Annals of internal medicine, 122(1), 1995, pp. 24-32
Citation: J. Batterman et al., IN-VITRO RELEASE OF SOLUBLE CD23(SCD23) IN RAGWEED-SENSITIVE VS NONATOPIC PATIENTS WITH ANTIGEN-E STIMULATION, Journal of allergy and clinical immunology, 93(1), 1994, pp. 250-250
Authors:
SPECTOR SA
GELBER RD
MCGRATH N
WARA D
BARZILAI A
ABRAMS E
BRYSON YJ
DANKNER WM
LIVINGSTON RA
CONNOR EM
SHEARER WT
DOYLE M
HANSON CG
LAFLEN J
PELTON SI
COOPER ER
REGAN AM
TOLTZIS P
ZUCKER M
CHANCE M
YOGEV R
CHADWICK E
BAKER RC
SIEGEL R
PITT J
GERSHON AA
KANEM N
NESHEIM SR
NAHMIAS AJ
KEYSERLING HL
SAWYER MK
DOSSETT J
EYSTER ME
CUBBLE LJ
YOLKEN R
MODLIN J
VINK P
WARFORD R
HEATON S
HODES D
SACKS HS
MCSHERRY G
OLESKE J
PICARDI J
COLABELLI N
GUPTA A
BORKOWSKY W
CHANDWANI S
RIGAUD M
KAUL A
BRADY MT
HUNKLER JA
CRIM LB
BONAGURA VR
VALACER DJ
BAKSHI S
GRIECO MH
RIVERS J
MCKINLEY G
FIKRIG S
VANDYKE RB
ALCHEDIAK T
DEVEIKIS A
WONG V
CHURCH J
DORENBAUM A
PETRU A
TREBITHICK D
RICH K
CHEESEMAN S
SULLIVAN JL
LUZURIAGA K
JONES CR
GOODROAD BK
BALFOUR HH
DIAZ C
LUGO L
FLORES L
RIVERA C
BURCHETT SK
MOHAN K
FOSTER I
COREY L
STORCH G
BREUKLANDER L
ROYAL M
Citation: Sa. Spector et al., CONTROLLED TRIAL OF INTRAVENOUS IMMUNE GLOBULIN FOR THE PREVENTION OFSERIOUS BACTERIAL-INFECTIONS IN CHILDREN RECEIVING ZIDOVUDINE FOR ADVANCED HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION, The New England journal of medicine, 331(18), 1994, pp. 1181-1187
Citation: Mm. Reddy et Mh. Grieco, ELEVATED LEVELS OF SOLUBLE CD54 (ICAM-1) IN HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION, Journal of clinical laboratory analysis, 7(5), 1993, pp. 269-272
Citation: Mm. Reddy et Mh. Grieco, CHANGED CIRCULATING CD35 LEVELS AND UNCHANGED CD71 LEVELS IN PATIENTSWITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION, The Journal of immunology, 150(8), 1993, pp. 317-317
Authors:
EDLIN BR
ATTOE LS
TOKARS JI
GRIECO MH
STROUD L
SORDILLO EM
WILLIAMS J
SCHNEIDER N
GILLIGAN ME
HOLMBERG SD
Citation: Br. Edlin et al., RECOGNITION AND TREATMENT OF PRIMARY MULTIDRUG-RESISTANT TUBERCULOSISIN HIV-INFECTED PATIENTS, The American review of respiratory disease, 147(4), 1993, pp. 489-489